|
Alpine Immune Sciences Inc (NASDAQ: ALPN) |
|
Alpine Immune Sciences Inc
ALPN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Alpine Immune Sciences Inc 's sales fell
by -25.09 % in the first quarter of 2024 from the same quarter a year ago.
Ranking at No. 3455
Major Pharmaceutical Preparations industry recorded
growth of revenues by 0.35 %
Alpine Immune Sciences Inc net loss increased from $-13 millions, to $-18 millions in first quarter of 2024,
• More on ALPN's Growth
|
|
Alpine Immune Sciences Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 224.09 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 73.6.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
• More on ALPN's Valuation
|
|
|
|
|
Alpine Immune Sciences Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 224.09 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 73.6.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
Alpine Immune Sciences Inc Price to Book Ratio is at 12.5 lower than Industry Avg. of 33.79. and higher than S&P 500 Avg. of 0.01
• More on ALPN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com